Latest Breaking News On - உள்ளார்ந்த பார்மா - Page 6 : vimarsana.com

Outcome of Innate Pharma’s Annual General Meeting May 28, 2021 16:01 ET | Source: INNATE PHARMA INNATE PHARMA Marseille, FRANCE MARSEILLE, France, May 28, 2021 (GLOBE NEWSWIRE) Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announced the voting results of its shareholders at the Annual General Meeting (“AGM”), which took place on May 28, 2021, in Marseille, France without the physical presence of its shareholders. All resolutions were voted on in accordance with the Executive Board’s recommendations. A total of 178 votes were cast out of a total of 31,717,812 shares giving right to 32,180,682 voting rights, representing a quorum of 40.141%. During the meeting, all seven members of the Supervisory Board who were up for election were re-elected. Pascale Boissel’s mandate lasts until the AGM in 2022 and Novo Nordisk A/S, represented by Marcus Schindler,

Pascale boisselMarcus schindlerBristol myers squibbNovo nordiskCompany annual report on formFrench financial markets authorityExchange commissionEuronext parisAnnual general meetingExecutive boardSupervisory boardChief scientific officerInnate pharmaPrivate securities litigation reform actRisk factorsUniversal registration document